Actively Recruiting
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
Led by Linda Chan, MD · Updated on 2025-07-22
167
Participants Needed
1
Research Sites
443 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of this evaluation is to see if this treatment will help patients with your condition and to evaluate the effect of this treatment on your quality of life over time. Radiosurgery is a non-invasive treatment technique used to treat tumors. Despite the word "surgery" in the name, the technology does not remove the tumor with a surgical knife. Instead, a focused, high-intensity beam of radiation targets the tumor, while minimizing dose to surrounding normal healthy tissue.
CONDITIONS
Official Title
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed prostate adenocarcinoma
- Biopsy performed within 12 months before registration unless in high risk arm where repeat biopsy is discretionary
- Clinical Stage I-IV, MX-M0 determined by exam, CT, MRI, or Bone Scan
- Bone scan required for Boost Risk Group or if clinically indicated
- Prostate volume recommended to be 100 cc or less measured by CT or ultrasound within 90 days
- ECOG performance status of 0 or 1
- Completion of patient questionnaires
- Signed informed consent
You will not qualify if you...
- Prior prostatectomy or cryotherapy of the prostate
- Previous radiotherapy to the prostate or lower pelvis
- Presence of implanted hardware or material preventing appropriate treatment planning or delivery as judged by investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MemorialCare Saddleback Medical Center
Laguna Hills, California, United States, 92653
Actively Recruiting
Research Team
L
Linda Chan, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here